4//SEC Filing
NOVELION THERAPEUTICS INC. 4
Accession 0001104659-16-163881
CIK 0000827809operating
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:08 PM ET
Size
5.8 KB
Accession
0001104659-16-163881
Insider Transaction Report
Form 4
Plutzky Jorge MD
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-12-22+9,600→ 9,600 totalExercise: $8.65Exp: 2026-12-22→ Common Shares (9,600 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]The common shares underlying this stock option award will vest in equal monthly installments over 36 months, beginning one month after the grant date.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000827809
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 4:08 PM ET
- Size
- 5.8 KB